Histone Deacetylases as Targets for Antitrypanosomal Drugs

Future Science OA - United Kingdom
doi 10.4155/fsoa-2018-0037
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Science Ltd

Related search

Histone Deacetylases as Targets for Treatment of Multiple Diseases

Clinical Science
Medicine
2013English

Class I and Class II Histone Deacetylases Are Potential Therapeutic Targets for Treating Pancreatic Cancer

PLoS ONE
Multidisciplinary
2012English

Innovative Strategies for Selective Inhibition of Histone Deacetylases

Cell Chemical Biology
Molecular MedicineMolecular BiologyPharmacologyBiochemistryClinical BiochemistryDrug Discovery
2016English

Regulating Histone Acetyltransferases and Deacetylases

EMBO Reports
BiochemistryGeneticsMolecular Biology
2003English

Inteins as Targets for Potential Antimycobacterial Drugs

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2003English

Developing a Novel Indolocarbazole as Histone Deacetylases Inhibitor Against Leukemia Cell Lines

Journal of Analytical Methods in Chemistry
InstrumentationComputer Science ApplicationsAnalytical ChemistryChemical Engineering
2015English

Regulation of Kidney Development by Histone Deacetylases

Pediatric Nephrology
Child HealthPediatricsPerinatologyNephrology
2011English

Drugs Acting on Central Nervous System (CNS) Targets as Leads for Non-CNS Targets

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2014English

Ssn6-Tup1 Interacts With Class I Histone Deacetylases Required for Repression

Genes and Development
GeneticsDevelopmental Biology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy